CELLEBRITE DI LTD (CLBT) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CLBT • IL0011794802

13.95 USD
-0.33 (-2.31%)
At close: Feb 4, 2026
13.95 USD
0 (0%)
After Hours: 2/4/2026, 8:10:55 PM
Fundamental Rating

6

Taking everything into account, CLBT scores 6 out of 10 in our fundamental rating. CLBT was compared to 278 industry peers in the Software industry. CLBT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CLBT is not valued too expensively and it also shows a decent growth rate. These ratings could make CLBT a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CLBT was profitable.
  • CLBT had a positive operating cash flow in the past year.
  • In multiple years CLBT reported negative net income over the last 5 years.
  • Each year in the past 5 years CLBT had a positive operating cash flow.
CLBT Yearly Net Income VS EBIT VS OCF VS FCFCLBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

  • With an excellent Return On Assets value of 9.15%, CLBT belongs to the best of the industry, outperforming 81.65% of the companies in the same industry.
  • The Return On Equity of CLBT (17.05%) is better than 84.53% of its industry peers.
  • CLBT has a Return On Invested Capital of 9.38%. This is amongst the best in the industry. CLBT outperforms 83.45% of its industry peers.
  • CLBT had an Average Return On Invested Capital over the past 3 years of 7.06%. This is below the industry average of 10.78%.
  • The 3 year average ROIC (7.06%) for CLBT is below the current ROIC(9.38%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.15%
ROE 17.05%
ROIC 9.38%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
CLBT Yearly ROA, ROE, ROICCLBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

  • CLBT has a better Profit Margin (16.74%) than 79.86% of its industry peers.
  • The Operating Margin of CLBT (13.47%) is better than 79.86% of its industry peers.
  • CLBT's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CLBT (83.96%) is better than 90.29% of its industry peers.
  • In the last couple of years the Gross Margin of CLBT has remained more or less at the same level.
Industry RankSector Rank
OM 13.47%
PM (TTM) 16.74%
GM 83.96%
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
CLBT Yearly Profit, Operating, Gross MarginsCLBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CLBT is destroying value.
  • The number of shares outstanding for CLBT has been increased compared to 1 year ago.
  • CLBT has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLBT Yearly Shares OutstandingCLBT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CLBT Yearly Total Debt VS Total AssetsCLBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • CLBT has an Altman-Z score of 6.41. This indicates that CLBT is financially healthy and has little risk of bankruptcy at the moment.
  • CLBT has a better Altman-Z score (6.41) than 82.73% of its industry peers.
  • There is no outstanding debt for CLBT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.41
ROIC/WACC0.97
WACC9.7%
CLBT Yearly LT Debt VS Equity VS FCFCLBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • CLBT has a Current Ratio of 2.11. This indicates that CLBT is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.11, CLBT is doing good in the industry, outperforming 60.79% of the companies in the same industry.
  • CLBT has a Quick Ratio of 2.08. This indicates that CLBT is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CLBT (2.08) is better than 60.79% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 2.08
CLBT Yearly Current Assets VS Current LiabilitesCLBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.98% over the past year.
  • CLBT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.37%.
  • Measured over the past years, CLBT shows a quite strong growth in Revenue. The Revenue has been growing by 18.47% on average per year.
EPS 1Y (TTM)6.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)18.37%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%17.94%

3.2 Future

  • Based on estimates for the next years, CLBT will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.94% on average per year.
  • The Revenue is expected to grow by 16.59% on average over the next years. This is quite good.
EPS Next Y23.61%
EPS Next 2Y14.48%
EPS Next 3Y14.46%
EPS Next 5Y12.94%
Revenue Next Year18.45%
Revenue Next 2Y17.87%
Revenue Next 3Y17.66%
Revenue Next 5Y16.59%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CLBT Yearly Revenue VS EstimatesCLBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
CLBT Yearly EPS VS EstimatesCLBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 30.33 indicates a quite expensive valuation of CLBT.
  • Compared to the rest of the industry, the Price/Earnings ratio of CLBT is on the same level as its industry peers.
  • CLBT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.25.
  • Based on the Price/Forward Earnings ratio of 25.34, the valuation of CLBT can be described as expensive.
  • 60.07% of the companies in the same industry are more expensive than CLBT, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CLBT to the average of the S&P500 Index (27.50), we can say CLBT is valued inline with the index average.
Industry RankSector Rank
PE 30.33
Fwd PE 25.34
CLBT Price Earnings VS Forward Price EarningsCLBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • CLBT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CLBT is cheaper than 60.79% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLBT indicates a somewhat cheap valuation: CLBT is cheaper than 68.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.51
EV/EBITDA 36.64
CLBT Per share dataCLBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

  • CLBT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of CLBT may justify a higher PE ratio.
  • A more expensive valuation may be justified as CLBT's earnings are expected to grow with 14.46% in the coming years.
PEG (NY)1.28
PEG (5Y)N/A
EPS Next 2Y14.48%
EPS Next 3Y14.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CLBT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CELLEBRITE DI LTD

NASDAQ:CLBT (2/4/2026, 8:10:55 PM)

After market: 13.95 0 (0%)

13.95

-0.33 (-2.31%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12
Earnings (Next)02-11
Inst Owners48.65%
Inst Owner Change-0.05%
Ins Owners0.63%
Ins Owner ChangeN/A
Market Cap3.41B
Revenue(TTM)455.90M
Net Income(TTM)76.33M
Analysts84.29
Price Target25.21 (80.72%)
Short Float %4.7%
Short Ratio5.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.18%
Min EPS beat(2)9.55%
Max EPS beat(2)12.81%
EPS beat(4)4
Avg EPS beat(4)9.8%
Min EPS beat(4)0.93%
Max EPS beat(4)15.93%
EPS beat(8)8
Avg EPS beat(8)38.68%
EPS beat(12)12
Avg EPS beat(12)58.72%
EPS beat(16)13
Avg EPS beat(16)32.65%
Revenue beat(2)1
Avg Revenue beat(2)0.12%
Min Revenue beat(2)-1.03%
Max Revenue beat(2)1.27%
Revenue beat(4)1
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-3.58%
Max Revenue beat(4)1.27%
Revenue beat(8)5
Avg Revenue beat(8)1.02%
Revenue beat(12)8
Avg Revenue beat(12)0.86%
Revenue beat(16)9
Avg Revenue beat(16)-0.08%
PT rev (1m)0%
PT rev (3m)4.43%
EPS NQ rev (1m)-0.47%
EPS NQ rev (3m)0.47%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)3.97%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)0.71%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.7%
Valuation
Industry RankSector Rank
PE 30.33
Fwd PE 25.34
P/S 7.48
P/FCF 24.51
P/OCF 22.33
P/B 7.62
P/tB 8.33
EV/EBITDA 36.64
EPS(TTM)0.46
EY3.3%
EPS(NY)0.55
Fwd EY3.95%
FCF(TTM)0.57
FCFY4.08%
OCF(TTM)0.62
OCFY4.48%
SpS1.86
BVpS1.83
TBVpS1.67
PEG (NY)1.28
PEG (5Y)N/A
Graham Number4.35
Profitability
Industry RankSector Rank
ROA 9.15%
ROE 17.05%
ROCE 11.87%
ROIC 9.38%
ROICexc N/A
ROICexgc N/A
OM 13.47%
PM (TTM) 16.74%
GM 83.96%
FCFM 30.51%
ROA(3y)-9.14%
ROA(5y)-1.85%
ROE(3y)-54.72%
ROE(5y)N/A
ROIC(3y)7.06%
ROIC(5y)7.59%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.94%
ROCE(5y)9.6%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y10.9%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.66%
GM growth 5Y1.3%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 127.51%
Cap/Sales 2.98%
Interest Coverage 250
Cash Conversion 211.92%
Profit Quality 182.24%
Current Ratio 2.11
Quick Ratio 2.08
Altman-Z 6.41
F-Score6
WACC9.7%
ROIC/WACC0.97
Cap/Depr(3y)92.67%
Cap/Depr(5y)99.76%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y23.61%
EPS Next 2Y14.48%
EPS Next 3Y14.46%
EPS Next 5Y12.94%
Revenue 1Y (TTM)18.37%
Revenue growth 3Y17.68%
Revenue growth 5Y18.47%
Sales Q2Q%17.94%
Revenue Next Year18.45%
Revenue Next 2Y17.87%
Revenue Next 3Y17.66%
Revenue Next 5Y16.59%
EBIT growth 1Y9.3%
EBIT growth 3Y30.51%
EBIT growth 5YN/A
EBIT Next Year39.48%
EBIT Next 3Y27.4%
EBIT Next 5Y25.56%
FCF growth 1Y58.39%
FCF growth 3Y63.25%
FCF growth 5Y65.07%
OCF growth 1Y62.48%
OCF growth 3Y54.2%
OCF growth 5Y52.3%

CELLEBRITE DI LTD / CLBT FAQ

What is the fundamental rating for CLBT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CLBT.


What is the valuation status of CELLEBRITE DI LTD (CLBT) stock?

ChartMill assigns a valuation rating of 4 / 10 to CELLEBRITE DI LTD (CLBT). This can be considered as Fairly Valued.


What is the profitability of CLBT stock?

CELLEBRITE DI LTD (CLBT) has a profitability rating of 7 / 10.


How financially healthy is CELLEBRITE DI LTD?

The financial health rating of CELLEBRITE DI LTD (CLBT) is 8 / 10.


What is the expected EPS growth for CELLEBRITE DI LTD (CLBT) stock?

The Earnings per Share (EPS) of CELLEBRITE DI LTD (CLBT) is expected to grow by 23.61% in the next year.